Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective: The Veterans Affairs (VA) Rheumatoid Arthritis (VARA) registry and the VA Pharmacy Benefits Management database were linked to determine the association of methotrexate (MTX) adherence with rheumatoid arthritis (RA) disease activity. Methods: For each patient, the medication possession ratio (MPR) was calculated for the first episode of MTX exposure of a duration of ≥12 weeks for both new and established MTX users. High MTX adherence was defined as an MPR ≥0.80 and low MTX adherence was defined as an MPR <0.80. For each patient, the mean Disease Activity Score with 28 joints (DAS28) score, erythrocyte sedimentation rate (ESR), and C‐reaction protein (CRP) level observed during registry followup were compared in high‐ versus low‐adherence groups. Results: In 455 RA patients, the prescribed doses of MTX (mean ± SD 16 ± 4 mg versus 16 ± 4 mg; P = 0.6) were similar in high‐adherence patients (n = 370) in comparison to low‐adherence patients (n = 85). However, the actual observed MTX doses taken by patients were significantly higher in the high‐adherence group (mean ± SD 16 ± 5 mg versus 11 ± 3 mg; P < 0.001). DAS28 (mean ± SD 3.6 ± 1.2 versus 3.9 ± 1.5; P < 0.02), ESR (mean ± SD 24 ± 18 versus 29 ± 24 mm/hour; P = 0.05), and CRP level (mean ± SD 1.2 ± 1.3 versus 1.6 ± 1.5 mg/dl; P < 0.03) were lower in the high‐adherence group compared to those with low MTX adherence. These variances were not explained by differences in baseline demographic features, concurrent treatments, or whether MTX was initiated before or after VARA enrollment. Conclusion: High MTX adherence was associated with improved clinical outcomes in RA patients treated with MTX. Adjustment for potential confounders did not alter the estimated effect of adherence. These results demonstrate the advantages of being able to merge clinical observations with pharmacy databases to evaluate antirheumatic drugs in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1007 · Cited by 1,383 · cited 1×
“Treatment adherence has been associated with several other factors, including cognitive (31,32) and psychological impairment (31,33,34), complex dosing schedules (33), treatment of an asymptomatic disease (35), medication side effects (34), substance abuse (27,36), barriers to obtaining medication (including costs) (3…”
BackgroundPredictors of Adherence With Antihypertensive and Lipid-Lowering Therapy
Chapman, R. H. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1147 · Cited by 506
Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans
Doshi, J. A., Zhu, J., Lee, B. Y., Kimmel, S. E., & Volpp, K. G. (2009) · Circulation · doi:10.1161/circulationaha.108.783944 · Cited by 184 · cited 2×
“This relatively favorable rate of treatment adherence is also higher than commonly reported in patients receiving medications for chronic conditions such as hypertension (21), hyperlipidemia (21,22), and diabetes mellitus (23).”
BackgroundMethodvan Servellen, G., Chang, B., Garcia, L., & Lombardi, E. (2002) · AIDS Patient Care and STDs · doi:10.1089/10872910260066705 · Cited by 133 · cited 1×
“Treatment adherence has been associated with several other factors, including cognitive (31,32) and psychological impairment (31,33,34), complex dosing schedules (33), treatment of an asymptomatic disease (35), medication side effects (34), substance abuse (27,36), barriers to obtaining medication (including costs) (3…”
Background
Cited by
Gabay, C., Emery, P., van Vollenhoven, R., Dikranian, A., Alten, R., Pavelka, K., Klearman, M., Musselman, D., Agarwal, S., Green, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60250-0 · Cited by 672
George, M. D., Baker, J. F., Winthrop, K., Hsu, J. Y., Wu, Q., Chen, L., Xie, F., Yun, H., & Curtis, J. R. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1594 · Cited by 198
“Continuous use was defined as no gaps in treatment greater than 90 days based on the days' supply from prescription fills or expected infusion intervals for infused therapies (21).”
BackgroundSelf-citation
Metadata
- Authors
- Cannon, G. W., Mikuls, T. R., Hayden, C. L., Ying, J., Curtis, J. R., Reimold, A. M., Caplan, L., Kerr, G. S., Richards, J. S., Johnson, D. S., & Sauer, B. C.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2011-11-29
- Volume
- 63
- Issue
- 12
- Pages
- 1680-1690
- ISSN
- 0893-7524 (ISSN-L)
- 2151-464X
- 2151-4658
- OpenAlex
- W2128509298
- Cited by
- 93
- References
- 4
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice. https://app.cochat.ai/papers/10.1002/acr.20629
- The paper
- Cannon, G. W., Mikuls, T. R., Hayden, C. L., Ying, J., Curtis, J. R., Reimold, A. M., Caplan, L., Kerr, G. S., Richards, J. S., Johnson, D. S., & Sauer, B. C. (2011). Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice. Arthritis Care & Research. https://doi.org/10.1002/acr.20629
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.